Skip to main content
CriticalFDAfda-F-1081-2022LISTERIA

Hippie Organics- French Beans, 1Lb, UPC 1588701137

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (listeria). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
1,874
Recall Date
April 14, 2022
Issuing Agency
Hazard
Listeria

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1081-2022.

Potential to be contaminated with Listeria monocytogenes. Firm notified FDA of positive result for Hippie Organics- Alpine Fresh French Bean Lot IM313626

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1081-2022.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Alpine Fresh, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1081-2022.

Alpine Fresh, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Alpine Fresh, Inc. Recall FAQ

Alpine Fresh, Inc. is the subject of a food safety report: Hippie Organics- French Beans, 1Lb, UPC 1588701137. The notice was published on April 14, 2022 by the U.S. Food and Drug Administration (FDA). Approximately 1,874 units are potentially affected.